Drug intelligence / Profile preview

UThymoKidney

Development stage
Preclinical
Lead developer
United Therapeutics
Administration
Surgical Implantation
01

Overview

**UThymoKidney** is an investigational xenotransplantation product developed by United Therapeutics for **end-stage renal disease**. It consists of a kidney from a GalSafe donor pig carrying a single **GGTA1** gene knockout, transplanted together with thymus tissue from the same donor pig. Loss of alpha-1,3-galactosyltransferase prevents expression of the alpha-gal carbohydrate antigen, reducing a major source of immediate xenograft rejection; the accompanying thymic tissue is intended to promote recipient immune recognition of the graft as self and reduce rejection risk. The EXTEND program is evaluating its safety and efficacy in patients with ESRD. ([ir.unither.com](https://ir.unither.com/~/media/Files/U/United-Therapeutics-IR/documents/press-releases/2024/24-04-2024-bleecker.pdf))

Other names
GGTA1 KO ThymokidneyGGTA-1 KO ThymokidneyGGTA 1 KO ThymokidneyUThymoKidney
02

Targets

GGTA1 (Alpha-1,3-galactosyltransferase)

Beyond the preview

Go deeper on UThymoKidney.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UThymoKidney.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call